Literature DB >> 9528009

Peptide mimics of a tumor antigen induce functional cytotoxic T cells.

V Apostolopoulos1, S A Lofthouse, V Popovski, G Chelvanayagam, M S Sandrin, I F McKenzie.   

Abstract

The ability to mimic peptide/peptide and/or peptide/carbohydrate structures may be important in generating cross-reactive antibodies for autoimmune and other diseases. We show that the peptide sequence DAHWESWL can mimic the conformation of the unrelated MUC1 peptide SAPDTRPAP(G). Mice immunized with mannan-MUC1-peptides make cytotoxic T lymphocytes (CTLs) and are protected from MUC1+ tumors. We show that the same specific anti-MUC1 responses can be produced by immunizing with the DAHWESWL peptide; furthermore, specific tumor protection is obtained in a manner similar to that with MUC1 immunization. The DAHWESWL peptide immunization leads to CTLs that recognize H2Dd and H2Ld but not H2b or human leukocyte antigens-group A (HLA-A) *0201 presented MUC1 peptides. However, mutation of the DAHWESWL peptide to a more HLA-A*0201-compatible structure with appropriate anchors (DLHWASWV), leads to the production of CTLs in HLA-A*0201 mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9528009     DOI: 10.1038/nbt0398-276

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  9 in total

1.  Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.

Authors:  Dodie S Pouniotis; Vasso Apostolopoulos; Geoffrey A Pietersz
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

2.  Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells.

Authors:  Kuo-Ching Sheng; Dodie S Pouniotis; Mark D Wright; Choon Kit Tang; Eliada Lazoura; Geoffrey A Pietersz; Vasso Apostolopoulos
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

3.  Structural allele-specific patterns adopted by epitopes in the MHC-I cleft and reconstruction of MHC:peptide complexes to cross-reactivity assessment.

Authors:  Dinler A Antunes; Gustavo F Vieira; Maurício M Rigo; Samuel P Cibulski; Marialva Sinigaglia; José A B Chies
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

4.  Salmonella enterica serovar Typhi live vector vaccines delivered intranasally elicit regional and systemic specific CD8+ major histocompatibility class I-restricted cytotoxic T lymphocytes.

Authors:  Marcela F Pasetti; Rosangela Salerno-Gonçalves; Marcelo B Sztein
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 5.  Targeting antigens to dendritic cell receptors for vaccine development.

Authors:  Vasso Apostolopoulos; Theresia Thalhammer; Andreas G Tzakos; Lily Stojanovska
Journal:  J Drug Deliv       Date:  2013-10-08

6.  The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer.

Authors:  Vanessa Barriga; Nyanbol Kuol; Kulmira Nurgali; Vasso Apostolopoulos
Journal:  Cancers (Basel)       Date:  2019-08-19       Impact factor: 6.575

7.  The Long Road of Immunotherapeutics against Multiple Sclerosis.

Authors:  Vasso Apostolopoulos; Abdolmohamad Rostami; John Matsoukas
Journal:  Brain Sci       Date:  2020-05-11

8.  Immunisation with 'naïve' syngeneic dendritic cells protects mice from tumour challenge.

Authors:  M J Grimshaw; K Papazisis; G Picco; H Bohnenkamp; T Noll; J Taylor-Papadimitriou; J Burchell
Journal:  Br J Cancer       Date:  2008-02-05       Impact factor: 7.640

Review 9.  Novel Approaches in the Immunotherapy of Multiple Sclerosis: Cyclization of Myelin Epitope Peptides and Conjugation with Mannan.

Authors:  John M Matsoukas; Irene Ligielli; Christos T Chasapis; Konstantinos Kelaidonis; Vasso Apostolopoulos; Thomas Mavromoustakos
Journal:  Brain Sci       Date:  2021-11-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.